Hiroaki Aoki1, Masayo Aoki1, Jing Yang2, Eriko Katsuta1, Partha Mukhopadhyay1, Rajesh Ramanathan3, Ingrid A Woelfel1, Xuan Wang2, Sarah Spiegel4, Huiping Zhou2, Kazuaki Takabe5. 1. Division of Surgical Oncology, Department of Surgery, Virginia Commonwealth University School of Medicine, Richmond, Virginia; Department of Biochemistry and Molecular Biology, Virginia Commonwealth University School of Medicine, Richmond, Virginia. 2. Department of Microbiology and Immunology, Virginia Commonwealth University School of Medicine, Richmond, Virginia. 3. Division of Surgical Oncology, Department of Surgery, Virginia Commonwealth University School of Medicine, Richmond, Virginia. 4. Department of Biochemistry and Molecular Biology, Virginia Commonwealth University School of Medicine, Richmond, Virginia. 5. Division of Surgical Oncology, Department of Surgery, Virginia Commonwealth University School of Medicine, Richmond, Virginia; Department of Biochemistry and Molecular Biology, Virginia Commonwealth University School of Medicine, Richmond, Virginia; Division of Breast Surgery, Department of Surgical Oncology, Roswell Park Cancer Institute, Buffalo, New York. Electronic address: Kazuaki.takabe@roswellpark.org.
Abstract
BACKGROUND: With the recent emergence of conjugated bile acids as signaling molecules in cancer, a murine model of obstructive jaundice by cholestasis with long-term survival is in need. Here, we investigated the characteristics of three murine models of obstructive jaundice. METHODS: C57BL/6J mice were used for total ligation of the common bile duct (tCL), partial common bile duct ligation (pCL), and ligation of left and median hepatic bile duct with gallbladder removal (LMHL) models. Survival was assessed by Kaplan-Meier method. Fibrotic change was determined by Masson-Trichrome staining and Collagen expression. RESULTS: Overall, 70% (7 of 10) of tCL mice died by day 7, whereas majority 67% (10 of 15) of pCL mice survived with loss of jaundice. A total of 19% (3 of 16) of LMHL mice died; however, jaundice continued beyond day 14, with survival of more than a month. Compensatory enlargement of the right lobe was observed in both pCL and LMHL models. The pCL model demonstrated acute inflammation due to obstructive jaundice 3 d after ligation but jaundice rapidly decreased by day 7. The LHML group developed portal hypertension and severe fibrosis by day 14 in addition to prolonged jaundice. CONCLUSIONS: The standard tCL model is too unstable with high mortality for long-term studies. pCL may be an appropriate model for acute inflammation with obstructive jaundice, but long-term survivors are no longer jaundiced. The LHML model was identified to be the most feasible model to study the effect of long-term obstructive jaundice.
BACKGROUND: With the recent emergence of conjugated bile acids as signaling molecules in cancer, a murine model of obstructive jaundice by cholestasis with long-term survival is in need. Here, we investigated the characteristics of three murine models of obstructive jaundice. METHODS: C57BL/6J mice were used for total ligation of the common bile duct (tCL), partial common bile duct ligation (pCL), and ligation of left and median hepatic bile duct with gallbladder removal (LMHL) models. Survival was assessed by Kaplan-Meier method. Fibrotic change was determined by Masson-Trichrome staining and Collagen expression. RESULTS: Overall, 70% (7 of 10) of tCLmice died by day 7, whereas majority 67% (10 of 15) of pCLmice survived with loss of jaundice. A total of 19% (3 of 16) of LMHL mice died; however, jaundice continued beyond day 14, with survival of more than a month. Compensatory enlargement of the right lobe was observed in both pCL and LMHL models. The pCL model demonstrated acute inflammation due to obstructive jaundice 3 d after ligation but jaundice rapidly decreased by day 7. The LHML group developed portal hypertension and severe fibrosis by day 14 in addition to prolonged jaundice. CONCLUSIONS: The standard tCL model is too unstable with high mortality for long-term studies. pCL may be an appropriate model for acute inflammation with obstructive jaundice, but long-term survivors are no longer jaundiced. The LHML model was identified to be the most feasible model to study the effect of long-term obstructive jaundice.
Authors: Lauren A Licata; Cang T Nguyen; Rachel A Burga; Vincent Falanga; N Joseph Espat; Alfred Ayala; Mitchell Thorn; Richard P Junghans; Steven C Katz Journal: J Leukoc Biol Date: 2013-07-24 Impact factor: 4.962
Authors: Zhumei Xu; Olga L Tavares-Sanchez; Quanzhong Li; Josephine Fernando; Carmen M Rodriguez; Elaine J Studer; William M Pandak; Phillip B Hylemon; Gregorio Gil Journal: J Biol Chem Date: 2007-06-30 Impact factor: 5.157
Authors: Linda Feldbrügge; Z Gordon Jiang; Eva Csizmadia; Shuji Mitsuhashi; Stephanie Tran; Eric U Yee; Sonja Rothweiler; Kahini A Vaid; Jean Sévigny; Moritz Schmelzle; Yury V Popov; Simon C Robson Journal: Purinergic Signal Date: 2017-11-13 Impact factor: 3.765
Authors: Eriko Katsuta; Li Yan; Masayuki Nagahashi; Ali Raza; Jamie L Sturgill; Debra E Lyon; Omar M Rashid; Nitai C Hait; Kazuaki Takabe Journal: J Surg Res Date: 2017-06-29 Impact factor: 2.192